Updated Recommendation
A new evidence synthesis was published:2022, WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes.
View latest version (2022)Bibliographic Info
Recommendation
Recommended in favor
Strong
Antenatal corticosteroid therapy is recommended in women with hypertensive disorders in pregnancy who are at risk of imminent preterm birth
Notes and Remarks
An appropriate standard of care for the management of women with hypertensive disorders in pregnancy should be provided to the mother in addition to corticosteroid therapy in a hospital setting. n The GDG placed its emphasis on the benefits to the preterm infants in terms of reducing early morbidity and mortality outcomes, the low cost and wide availability of corticosteroid globally, the feasibility of implementing the intervention, and the potential impact on health-care resource use across settings, and therefore made a strong recommendation.